Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Singh Enakshi, Chief Financial Officer. Officer active across 1 company, notably Zymergen Inc.. Aggregated, 8 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €54k. History available since 26 October 2021. The latest transaction was filed on 3 October 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Singh Enakshi is Chief Financial Officer at Zymergen Inc. (XNAS). She has filed 8 forms in total, and across the 8 recent sampled filings between 2021-10-28 and 2022-10-19, sell transactions amount to EUR 54360 and the most frequent transaction nature is Sell.